Long-term effectiveness of tocilizumab in patients with rheumatoid arthritis, stratified by number of previous treatment failures with biologic agents: results from the German RABBIT cohort

In Germany, Tocilizumab (TCZ) is used for the treatment of rheumatoid arthritis both in biologic-naïve patients and those with previous failures of biologic disease-modifying antirheumatic drugs (bDMARDs). The long-term effectiveness and retention rates of TCZ in patients with different numbers of p...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Rheumatol Int
Autori principali: Baganz, Lisa, Richter, Adrian, Kekow, Jörn, Bussmann, Arnold, Krause, Andreas, Stille, Carsten, Listing, Joachim, Zink, Angela, Strangfeld, Anja
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Berlin Heidelberg 2017
Soggetti:
Cohort Studies
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5854739/
https://ncbi.nlm.nih.gov/pubmed/29143933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00296-017-3870-7
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi